"Before 2025, my research investigated how macrophage activation and metabolic reprogramming are shaped by TB-associated microenvironments, including TB–HIV co-infection, type 2 diabetes, and the lung microbiota, while also establishing human organoid-based models to study host–pathogen interactions and therapeutic responses."